Back to Search Start Over

17β-Hydroxysteroid dehydrogenases types 1 and 2: Enzymatic assays based on radiometric and mass-spectrometric detection.

Authors :
Sinreih M
Gjorgoska M
Möller G
Adamski J
Rižner TL
Source :
Methods in enzymology [Methods Enzymol] 2023; Vol. 689, pp. 201-234. Date of Electronic Publication: 2023 May 20.
Publication Year :
2023

Abstract

The 17β-hydroxysteroid dehydrogenase type 1 (HSD17B1) has a key role in estrogen biosynthesis as it catalyzes the reduction of estrone to the most potent estrogen, estradiol. Estradiol has a high affinity for estrogen receptors and thus stimulates their transactivation, which leads to cell proliferation and numerous other effects. HSD17B2 catalyzes the oxidation of estradiol to the less potent estrone, thereby decreasing estrogen receptor activation, which results in reduction of estrogen-associated effects. HSD17B1 and HSD17B2 overexpressing E.coli homogenates or recombinant enzymes can be used for screening and development of drugs against various pathologies such as cancer, endometriosis or osteoporosis. Here we describe the preparation of HSD17B1 and HSD17B2 bacterial homogenates and purified recombinant HSD17B1 protein as enzyme sources as well as enzymatic assays based on radiometric and mass-spectrometric detection for enzyme characterization.<br /> (Copyright © 2023. Published by Elsevier Inc.)

Details

Language :
English
ISSN :
1557-7988
Volume :
689
Database :
MEDLINE
Journal :
Methods in enzymology
Publication Type :
Academic Journal
Accession number :
37802571
Full Text :
https://doi.org/10.1016/bs.mie.2023.04.015